跳至主要内容
临床试验/NCT02486835
NCT02486835已完成不适用

Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold

Clalit Health Services4 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2015年12月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
4
主要终点
Change in night cough frequency score in the general population

研究概览

简要总结

Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. The intent of this study is to use a protective syrup with does not act as a sedative or as a potent mucolytic and measure its efficacy and safety versus placebo in children with moderate to severe night and daily cough. Cough is assessed with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.

详细描述

Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. Looking into mechanisms for cough management different from mucolytics, or sedatives, such as protection of irritated pharynx mucosa from post nasal drip or other irritating substances is theoretically sound and shows practical interesting results.

A parallel comparison of efficacy and tolerability between such protective mechanism (acting through a barrier and radical scavenging action) due to natural substances (honey, plantago lanceolata and thymus vulgaris) and placebo has not been done so far, in very young children, especially in a time frame of 4 days. The intent of this study is to use the protective syrup versus placebo in children with moderate to severe night and daily cough, measured with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.

Assessment of effectiveness of the protective cough syrup as compared to placebo is considered very interesting due to the mechanism of the remedy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • cough attributed to infection of the upper respiratory tract since less or equal than 7 days,
  • children aged 1 to 5 years
  • score of three or more of al least two of the following three questions relating to night cough, frequency of nocturnal cough, impact on sleep of child and impact on sleep of parent,
  • score of at least three of all questions assessing daytime cough considering the day prior to study entry
  • written consent by a parent.

排除标准

  • Children with a diagnosis of acute laryngotracheal bronchitis, pneumonia, asthma, sinusitis, allergic rhinitis, as well as chronic cardiac condition, or cystic fibrosis or any anatomical respiratory tract anomalies,
  • Children who received antihistamines or any cough medicine the day prior to study entry,
  • The administration of any steroid preparation by oral administration or inhalation on the day prior to study entry,
  • Known sensitivity to any component of placebo or to Plantago lanceolata or Thymus vulgaris, honey or any other component of the cough syrup.

研究组 & 干预措施

"Cough Syrup for adults and children"

Experimental

Marked (authorized) medical device acting by protecting the oropharynx, in a non pharmacological way, to reduce cough. It contains honey, plantago lanceolata, thymus vulgaris.Dosage form: syrup Dosage: 5 ml three times a day. Frequency: the duration of the study for each patient is 4 nights, 3 days.

干预措施: Cough syrup for adults and children (Device)

Placebo

Placebo Comparator

The placebo intervention is a syrup of same taste and colour without the protective components. Dosage form: syrup. Dosage: 5 ml three times a day Frequency: the duration of the study for each patient is 4 nights, 3 days.

干预措施: Placebo (Device)

结局指标

主要结局

Change in night cough frequency score in the general population

时间窗: baseline up to night 1

Night cough frequency is the most invasive element of distress to the child and family. The questionnaire rating night cough is filled in each morning relating to the passed night for four nights. The basal night score is the score of the night before enrollment.

次要结局

  • Change in night cough frequency score in the population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough frequency score in the female population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough frequency score in the male population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough severity score in the general population(baseline up to night 1)
  • Change in night cough severity score in the population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough bothersomeness score in the general population(baseline up to night 1)
  • Change in night cough bothersomeness score in the population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough influence on sleep of child score in the general population(baseline up to night 1)
  • Change in night cough influence on sleep of child score in the population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough influence on sleep of parent score in the general population(baseline up to night 1)
  • Change in night cough influence on sleep of parent score in the population coughing since 1-2 days(baseline up to night 1)
  • Change in night cough combined score in the general population(baseline up to night 1)
  • Change in night cough combined score in the population coughing since 1-2 days(baseline up to night 1)
  • Change in day cough frequency score in the general population(baseline up to day 2)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Avner Herman Cohen

Prof. Herman Avner Cohen

Clalit Health Services

研究点 (4)

Loading locations...

相似试验